Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Ines Chevolet
Profile
Projects
Publications
Activities
Awards & Distinctions
20
Results
2018
Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma
Lieve Brochez
Annabel Meireson
INES CHEVOLET
Nora Sundahl
Piet Ost
Vibeke Kruse
A1
Journal Article
in
NATURE COMMUNICATIONS
2018
Endothelial indoleamine 2,3-dioxygenase is correlated with microsatellite status in colorectal carcinoma and predicts worse prognosis
Annabel Meireson
INES CHEVOLET
Eva Hulstaert
Liesbeth Ferdinande
Piet Ost
Karen Geboes
Marc De Man
Dirk Van de Putte
Laurine Verset
Vibeke Kruse
et al.
C3
Conference
2018
Peritumoral endothelial indoleamine 2,3-dioxygenase expression is an early independent marker of disease relapse in colorectal cancer and is influenced by DNA mismatch repair profile
Annabel Meireson
INES CHEVOLET
Eva Hulstaert
Liesbeth Ferdinande
Piet Ost
Karen Geboes
Marc De Man
Dirk Van de Putte
Laurine Verset
Vibeke Kruse
et al.
A2
Journal Article
in
ONCOTARGET
2018
2017
A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma : evaluation of clinical and immunologic response
Katrien De Wolf
VIBEKE KRUSE
Nora Sundahl
Mireille Van Gele
INES CHEVOLET
Reinhart Speeckaert
Lieve Brochez
Piet Ost
A1
Journal Article
in
JOURNAL OF TRANSLATIONAL MEDICINE
2017
The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy
Lieve Brochez
INES CHEVOLET
Vibeke Kruse
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2017
2016
Comparison of ex vivo and in vivo dermoscopy in dermatopathologic evaluation of skin tumors
Marc Haspeslagh
Katrien Vossaert
Sven Lanssens
Michael Noe
Isabelle Hoorens
INES CHEVOLET
Ine De Wispelaere
Nele Degryse
Fabio Facchetti
Lieve Brochez
A1
Journal Article
in
JAMA DERMATOLOGY
2016
Total-body examination vs lesion-directed skin cancer screening
Isabelle Hoorens
Katrien Vossaert
Lore Pil
Barbara Boone
Sofie De Schepper
Katia Ongenae
Lieven Annemans
INES CHEVOLET
Lieve Brochez
A1
Journal Article
in
JAMA DERMATOLOGY
2016
Virale oncogenese van het merkelcelcarcinoom
Eva Hulstaert
INES CHEVOLET
Vibeke Kruse
Lieve Brochez
A2
Journal Article
in
TIJDSCHRIFT VOOR GENEESKUNDE
2016
2015
A short dermoscopy training increases diagnostic performance in both inexperienced and experienced dermatologists
INES CHEVOLET
Isabelle Hoorens
Astrid Janssens
Reinhart Speeckaert
Nanja van Geel
GEORGES VAN MAELE
Katrien Vossaert
Lieve Brochez
A1
Journal Article
in
AUSTRALASIAN JOURNAL OF DERMATOLOGY
2015
A translational exploration of melanoma immunology focused on indoleamine 2,3-dioxygenase : lessons for immunoprofiling and immunotherapy
INES CHEVOLET
Lieve Brochez
Mireille Van Gele
Dissertation
2015
Characterization of the in vivo immune network of IDO, tryptophan metabolism, PD-L1, and CTLA-4 in circulating immune cells in melanoma
INES CHEVOLET
Reinhart Speeckaert
Max Schreuer
B Neyns
Olga Krysko
Claus Bachert
B Hennart
D Allorge
Nanja van Geel
Mireille Van Gele
et al.
A1
Journal Article
in
ONCOIMMUNOLOGY
2015
Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanoma
INES CHEVOLET
Reinhart Speeckaert
Max Schreuer
Bart Neyns
Olga Krysko
Claus Bachert
Mireille Van Gele
Nanja van Geel
Lieve Brochez
A1
Journal Article
in
JOURNAL OF TRANSLATIONAL MEDICINE
2015
Phase I trial of stereotactic body radiotherapy with concurrent fixed dose ipilimumab in metastatic melanoma: dose limiting toxicity and abscopal effect
Katrien De Wolf
Piet Ost
VIBEKE KRUSE
Lieve Brochez
INES CHEVOLET
C3
Conference
2015
Systemic immune changes associated with adjuvant interferon-α2b-therapy in stage III melanoma patients: failure at the effector phase?
INES CHEVOLET
Max Schreuer
Reinhart Speeckaert
Bart Neyns
Isabelle Hoorens
Nanja van Geel
Vibeke Kruse
Benjamin Hennart
Delphine Allorge
Mireille Van Gele
et al.
A1
Journal Article
in
MELANOMA RESEARCH
2015
2014
Peritumoral indoleamine 2,3-dioxygenase expression in melanoma : an early marker of resistance to immune control?
INES CHEVOLET
Reinhart Speeckaert
Marc Haspeslagh
Bart Neyns
VIBEKE KRUSE
Max Schreuer
Mireille Van Gele
Nanja van Geel
Lieve Brochez
A1
Journal Article
in
BRITISH JOURNAL OF DERMATOLOGY
2014
2013
Hypomelanoses in children
Nanja van Geel
Marijn Speeckaert
INES CHEVOLET
Sofie De Schepper
Hilde Lapeere
Barbara Boone
Reinhart Speeckaert
A2
Journal Article
in
JOURNAL OF CUTANEOUS AND AESTHETIC SURGERY
2013
The effect of CD8+tumor-infiltrating lymphocytes on sentinel lymph node immune status
INES CHEVOLET
Reinhart Speeckaert
Barbara Boone
Nanja van Geel
Mireille Van Gele
Marc Haspeslagh
Lieve Brochez
C3
Conference
2013
miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells
Peter Dynoodt
Reinhart Speeckaert
Olivier De Wever
INES CHEVOLET
Lieve Brochez
Jo Lambert
Mireille Van Gele
A1
Journal Article
in
INTERNATIONAL JOURNAL OF ONCOLOGY
2013
2012
Clinical significance of Koebner's phenomenon in vitiligo
Nanja van Geel
Reinhart Speeckaert
J De Wolf
STEFANIE BRACKE
INES CHEVOLET
Lieve Brochez
Jo Lambert
A1
Journal Article
in
BRITISH JOURNAL OF DERMATOLOGY
2012
Immune mediated mechanisms of melanocyte destruction: paving the way for efficient immunotherapeutic strategies against melanoma
Reinhart Speeckaert
Nanja van Geel
Jo Lambert
Barbara Boone
INES CHEVOLET
Mireille Van Gele
Marijn Speeckaert
Lieve Brochez
Editorial material
2012